Research And Development
Europe
Health

AstraZeneca

2,725

$41.77
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.

+$0.11 (+0.26%) Today
-$0.70 (-1.64%) As of 8:00 PM EDT after-hours

Why Robinhood?

You can buy or sell AstraZeneca and other stocks, options, ETFs, and crypto commission-free!

About AZN

AstraZeneca PLC, also called AstraZeneca, is a holding company, which engages in the research, development, and manufacture of pharmaceutical products. Its pipeline are used for the following therapy areas: oncology, cardiovascular, renal, metabolism, and respiratory. Read More The company was founded on June 17, 1992 and is headquartered in Cambridge, the United Kingdom.

CEO
Pascal Soriot
Employees
64,400
Headquarters
Cambridge, Cambridgeshire
Founded
1992
Market Cap
105.97B
Price-Earnings Ratio
82.22
Dividend Yield
3.23
Average Volume
6.89M
High Today
$43.13
Low Today
$40.75
Open Price
$40.75
Volume
6.78M
52 Week High
$51.55
52 Week Low
$36.15

Collections

Research And Development
Europe
Health
Manufacturing
Cancer Prevention
Biotechnology
Medical
Biopharmaceutical

AZN News

Reuters17h

BRIEF-AstraZeneca Says Farxiga Reduced The Incidence Of Heart Failure Worsening Or Cardiovascular Death

March 28 (Reuters) - AstraZeneca PLC: * FARXIGA REDUCED THE INCIDENCE OF HEART FAILURE WORSENING OR CARDIOVASCULAR DEATH IN A SUB-ANALYSIS FROM LANDMARK PHASE
42
BenzingaMar 27

Talos Health Solutions Partners with AstraZeneca Pharmaceuticals to Educate Asthma Patients

LAKE MARY, Fla., March 27, 2020 /PRNewswire-PRWeb/ -- On March 27th, 2020, Talos Health Solutions, kicked off AsthmaCon 2020, a three-month online educational h
112
ReutersMar 26

BRIEF-AstraZeneca Says Lokelma Approved In Japan For Hyperkalaemia

March 26 (Reuters) - AstraZeneca PLC: * ASTRAZENECA PLC - LOKELMA APPROVED IN JAPAN FOR HYPERKALAEMIA * ASTRAZENECA - RESULTS IN JAPANESE PATIENTS WERE BROADL
11

AZN Earnings

$0.00
$0.53
$1.05
$1.58
Q2 2018
Q3 2018
Q4 2018
Q1 2019
Q2 2019
Q3 2019
Q4 2019
Q1 2020
Estimated
— per share
Actual
Available Apr 29, Pre-Market

People Also Bought

Pfizer

50,452

$30.80

-2.99%

Pfizer

50,452

$30.80

-2.99%

Merck

11,585

$71.22

-3.14%

Bristol-Myers Squibb

9,865

$52.79

+1.03%

AbbVie

30,488

$72.70

-1.53%

You May Also Like

JNUG
ATHM
ZIOP
PBBI
WB
IEFN
EEX
AMKBY
ATRS
RP

More AZN News

ReutersMar 25

BRIEF-Brightinsight Announces Global Digital Health Partnership With AstraZeneca

March 25 (Reuters) - AstraZeneca PLC: * BRIGHTINSIGHT ANNOUNCES GLOBAL DIGITAL HEALTH PARTNERSHIP WITH ASTRAZENECA Source text for Eikon: Further company cover
4
Robinhood Snacks newsletters and podcasts reflect the opinions of only the authors who are associated persons of Robinhood Financial LLC and do not reflect the views of Robinhood Markets, Inc. or any of its subsidiaries or affiliates. They are meant for informational purposes only, are not intended to serve as a recommendation to buy or sell any security in a self-directed Robinhood account or any other account, and are not an offer or sale of a security. They are also not research reports and are not intended to serve as the basis for any investment decision. Any third-party information provided therein does not reflect the views of Robinhood Markets, Inc., Robinhood Financial LLC, or any of their subsidiaries or affiliates. All investments involve risk and the past performance of a security or financial product does not guarantee future results or returns. Keep in mind that while diversification may help spread risk, it does not assure a profit or protect against loss. There is always the potential of losing money when you invest in securities or other financial products. Investors should consider their investment objectives and risks carefully before investing. The price of a given security may increase or decrease based on market conditions and customers may lose money, including their original investment. Robinhood Financial LLC, member FINRA/SIPC.

All investments involve risk and the past performance of a security, or financial product does not guarantee future results or returns. Securities offered through Robinhood Financial LLC, member FINRA/SIPC. To learn more about the information provided on this page, please see our Web Disclosures.

Buy AZN

Market Price$41.77
Commissions$0.00
Estimated Cost
$0.00
Sign up for a Robinhood Account to buy or sell AstraZeneca stock and options commission-free.
Search
LearnBlogCareersHelpLog InSign Up